ALLMedicine™ Cholera Center
Research & Reviews 1,971 results
https://doi.org/10.1097/01.NAJ.0000919688.58866.9a
The American Journal of Nursing;
Jan 27th, 2023 - Natural and human-made disasters have contributed to the rise in cases.
https://doi.org/10.4269/ajtmh.21-0708
The American Journal of Tropical Medicine and Hygiene; Lawrence Grant S, Lange S et. al.
Jan 24th, 2023 - Most cholera outbreaks in Bangladesh are seasonal, peaking in the dry and post-monsoon periods. Therefore, we investigated whether changes in water, sanitation, and hygiene (WASH) behavior in three populations in Bangladesh during the year could h...
https://doi.org/10.1016/j.neuroscience.2022.12.022
Neuroscience Miranda NC, Oliveira LM et. al.
Jan 24th, 2023 - Parkinson's disease (PD) is a motor disorder resulting from degeneration of dopaminergic neurons of substantia nigra pars compacta (SNpc), with classical and non-classical symptoms such as respiratory instability. An important region for breathing...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869508
BMC Public Health; Chisenga CC, Bosomprah S et. al.
Jan 24th, 2023 - Histo-blood group antigens (HBGAs) which include the ABO and Lewis antigen systems have been known for determining predisposition to infections. For instance, blood group O individuals have a higher risk of severe illness due to V. cholerae compar...
https://doi.org/10.1136/bmj.p141
BMJ (Clinical Research Ed.); Khoury P
Jan 20th, 2023 - Cholera is back but the world is looking away.|2023|Khoury P,|epidemiology,prevention & control,
Guidelines 1 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657988
MMWR. Morbidity and Mortality Weekly Report; Wong KK, Burdette E et. al.
May 12th, 2017 - Cholera, caused by infection with toxigenic Vibrio cholerae bacteria of serogroup O1 (>99% of global cases) or O139, is characterized by watery diarrhea that can be severe and rapidly fatal without prompt rehydration. Cholera is endemic in approxi...
Drugs 297 results see all →
Clinicaltrials.gov 110 results
https://clinicaltrials.gov/ct2/show/NCT05292508
Dec 28th, 2022 - The World Health Organization (WHO) defines antimicrobial resistance (AMR) as a situation where drugs used to treat microbial infection caused by bacteria, viruses, fungi and parasites no longer work to treat infection because of the changes in th...
https://clinicaltrials.gov/ct2/show/NCT05657782
Dec 20th, 2022 - The primary objectives of this study are: To evaluate the reactogenicity and the safety of a single-dose PanChol over a range of doses in healthy volunteers. To evaluate the immunogenicity of a single-dose PanChol over a range of doses as measured...
https://clinicaltrials.gov/ct2/show/NCT04750070
Dec 20th, 2022 - Background: Burden: Burden: Diarrhea is one of the leading causes of under-five childhood mortality and accounts for 8% of 5.4 million global under-5 deaths. Co-morbidity of severe acute malnutrition (SAM) and shock in children with diarrhea is as...
https://clinicaltrials.gov/ct2/show/NCT05559983
Dec 5th, 2022 - A total of 150 eligible participants will be recruited in 3 sequential dose cohorts: low-dose 5 µg, medium-dose 10 µg, and high-dose 25 µg. In each dose cohorts, the participants will be randomized in a blinded manner into three arms (vaccine anti...
https://clinicaltrials.gov/ct2/show/NCT03719066
Oct 5th, 2022 - This is an open label, randomized, phase 2 clinical trial of the immunogenicity of killed oral cholera vaccine (OCV) when the vaccine is administered to participants of three age cohorts (1-4 years, 5-14 years, and >14 years) and in three dose int...
News 262 results
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/732832
Research — Association between Conflict and Cholera in Nigeria and the Democratic Republic of the Congo
https://www.medpagetoday.com/infectiousdisease/covid19/102273
Dec 16th, 2022 - Note that some links may require subscriptions. An estimated 5.7% patients are misdiagnosed in the emergency department (ED) each year, representing about 7.4 million errors, 2.6 million harms, and more than 370,000 patients suffering permanent di...
https://www.medscape.com/viewarticle/985160
Dec 8th, 2022 - BEIJING (Reuters) - China on Wednesday announced the most sweeping changes to its resolute anti-COVID regime since the pandemic began three years ago, loosening rules that curbed the spread of the virus but sparked protests and hobbled the world's...
https://www.medscape.com/viewarticle/985159
Dec 8th, 2022 - BEIJING (Reuters) -China's national health authority said on Wednesday that asymptomatic COVID-19 cases and people with mild symptoms can quarantine at home, in the strongest sign yet that China is preparing its people to live with the disease. Mo...
https://www.medscape.com/viewarticle/984972
Dec 6th, 2022 - HONG KONG (Reuters) - China may announce 10 new COVID-19 easing measures as early as Wednesday, two sources with knowledge of the matter told Reuters, supplementing 20 unveiled in November that set off a wave of COVID easing steps nationwide. Thre...